TRX Gold (TRX) 6-K 14 Jan 25 Current report (foreign) Financial data

Cover

Cover	3 Months Ended
	Nov. 30, 2024
Cover [Abstract]
Document Type	6-K
Amendment Flag	false
Document Period End Date	Nov. 30, 2024
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2025
Current Fiscal Year End Date	--08-31
Entity File Number	001-32500
Entity Registrant Name	TRX GOLD Corporation
Entity Central Index Key	0001173643
Entity Address, Address Line One	277 Lakeshore Road East
Entity Address, Address Line Two	Suite 403
Entity Address, City or Town	Oakville
Entity Address, State or Province	ON
Entity Address, Country	CA
Entity Address, Postal Zip Code	L6J 1H9

Interim Condensed Consolidated

Interim Condensed Consolidated Statements of Financial Position (Unaudited) - USD ($) $ in Thousands	Nov. 30, 2024	Aug. 31, 2024
Current assets
Cash	$ 6,787	$ 8,331
Amounts receivable	2,307	1,958
Prepayments and other assets	1,215	1,246
Inventories	6,534	6,249
Total current assets	16,843	17,784
Other long-term assets	3,373	3,259
Mineral property, plant and equipment	82,416	77,817
Total assets	102,632	98,860
Current liabilities
Amounts payable and accrued liabilities	15,876	15,545
Income tax payable	840	1,411
Current portion of deferred revenue	1,322	1,653
Current portion of lease liabilities	903	401
Derivative financial instrument liabilities	1,454	2,273
Total current liabilities	20,395	21,283
Lease liabilities	1,951	942
Deferred income tax liability	10,796	9,505
Provision for reclamation	1,127	1,091
Total liabilities	34,269	32,821
Equity
Share capital	166,313	165,945
Share-based payments reserve	8,970	9,151
Warrants reserve	1,700	1,700
Accumulated deficit	(120,912)	(121,893)
Equity attributable to shareholders	56,071	54,903
Non-controlling interest	12,292	11,136
Total equity	68,363	66,039
Total equity and liabilities	$ 102,632	$ 98,860

Interim Condensed Consolidate_2

Interim Condensed Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Nov. 30, 2024	Nov. 30, 2023
Profit or loss [abstract]
Revenue	$ 12,528	$ 9,404
Cost of sales
Production costs	(5,846)	(4,508)
Royalty	(942)	(695)
Depreciation	(906)	(484)
Total cost of sales	(7,694)	(5,687)
Gross profit	4,834	3,717
General and administrative expenses	(1,425)	(2,211)
Change in fair value of derivative financial instruments	819	199
Foreign exchange losses	(77)	(80)
Interest and other expenses	(321)	(473)
Income before tax	3,830	1,152
Income tax expense	(1,693)	(1,191)
Net income (loss) and comprehensive income (loss)	2,137	(39)
Shareholders	981	(966)
Non-controlling interest	1,156	927
Net income (loss) and comprehensive income (loss)	$ 2,137	$ (39)
Basic (loss) earnings per share	$ 0	$ 0
Diluted (loss) earnings per share	$ 0	$ 0

Interim Condensed Consolidate_3

Interim Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($) $ in Thousands	Issued capital [member]	Reserve of share-based payments [member]	Reserve For Warrants [member]	Accumulated deficit [member]	Shareholders' equity [member]	Non-controlling interests [member]	Total
Beginning balance, value at Aug. 31, 2023	$ 164,816	$ 8,807	$ 1,700	$ (121,423)	$ 53,900	$ 7,156	$ 61,056
Beginning balance, shares at Aug. 31, 2023	277,625,317
IfrsStatementLineItems [Line Items]
Shares issued for share-based payments (Note 13)	$ 642	(632)			10		10
Shares issued for share-based payments, shares	1,465,417
Share-based compensation expense (Note 13)		865			865		865
Witholding tax impact on share-based payments		(357)			(357)		(357)
Net (loss) income for the period				(966)	(966)	927	(39)
Ending balance, value at Nov. 30, 2023	$ 165,458	8,683	1,700	(122,389)	53,452	8,083	61,535
Ending balance, shares at Nov. 30, 2023	279,090,734
IfrsStatementLineItems [Line Items]
Shares issued for share-based payments	$ 487	(489)			(2)		(2)
Shares issued for share-based payments, shares	1,100,002
Share-baseds compensation expense		1,153			1,153		1,153
Witholding tax impact on share-based payments		(196)			(196)		(196)
Net income for the period				496	496	3,053	3,549
Ending balance, value at Aug. 31, 2024	$ 165,945	9,151	1,700	(121,893)	54,903	11,136	66,039
Ending balance, shares at Aug. 31, 2024	280,190,736
IfrsStatementLineItems [Line Items]
Shares issued for share-based payments (Note 13)	$ 368	(370)			(2)		(2)
Shares issued for share-based payments, shares	519,215
Share-based compensation expense (Note 13)		189			189		189
Net income for the period				981	981	1,156	2,137
Ending balance, value at Nov. 30, 2024	$ 166,313	$ 8,970	$ 1,700	$ (120,912)	$ 56,071	$ 12,292	$ 68,363
Ending balance, shares at Nov. 30, 2024	280,709,951

Interim Condensed Consolidate_4

Interim Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Nov. 30, 2024	Nov. 30, 2023
Operating
Net income (loss)	$ 2,137	$ (39)
Adjustments for items not involving cash:
Non-cash items	1,547	2,955
Changes in non-cash working capital:
(Increase) decrease in amounts receivable	(209)	1,032
Increase in inventories	(446)	(343)
Decrease in prepaid and other assets	31	79
(Decrease) increase in amounts payable and accrued liabilities	(87)	1,863
Decrease in income tax payable	(592)	(408)
Cash provided by operating activities	2,381	5,139
Investing
Exploration and evaluation assets and expenditures	(431)	(91)
Purchase of mineral property, plant and equipment	(3,155)	(3,683)
Increase in other long-term assets	(114)	(286)
Cash used in investing activities	(3,700)	(4,060)
Financing
Withholding taxes on settlement of share-based payments	(2)	(357)
Lease payments	(223)	(24)
Cash used in financing activities	(225)	(381)
Net (decrease) increase in cash	(1,544)	698
Cash at beginning of the period	8,331	7,629
Cash at end of the period	6,787	8,327
Taxes paid in cash	994	700
Interest paid on leases	$ 70	$ 1

Nature of operations

Nature of operations	3 Months Ended
	Nov. 30, 2024
Nature Of Operations
Nature of operations	1. Nature of operations TRX Gold Corporation (“TRX Gold” or the “Company”) was incorporated in the Province of Alberta on July 5, 1990 under the Business Corporations Act (Alberta). The Company’s principal business activity is the exploration, development and production of mineral property interests in the United Republic of Tanzania (“Tanzania”). The Company’s registered office is 400 3 rd The Company’s common shares are listed on the Toronto Stock Exchange in Canada (TSX: TRX) and NYSE American in the United States of America (NYSE American: TRX). The Company is primarily focused on development and mining operations, exploring, and evaluating its mineral properties. The business of exploring and mining for minerals involves a high degree of risk. The underlying value of the mineral properties is dependent upon the existence and economic recovery of mineral resources and reserves, the ability to raise long-term financing to complete the development of the properties, government policies and regulations, and upon future profitable production or, alternatively, upon the Company’s ability to dispose of its interest on an advantageous basis; all of which are uncertain.

Basis of preparation

Basis of preparation	3 Months Ended
	Nov. 30, 2024
Notes and other explanatory information [abstract]
Basis of preparation	2. Basis of preparation a) Statement of compliance The Company’s interim condensed consolidated financial statements have been prepared in accordance with International Accounting Standards 34, Interim Financial Reporting These interim condensed consolidated financial statements were approved by the Board of Directors of the Company on January 9, 2025. b) Basis of presentation and measurement These interim condensed consolidated financial statements have been prepared on a going concern basis under the historical cost basis, except for certain financial assets and liabilities which are measured at fair value as disclosed in Note 18. All amounts in these interim condensed consolidated financial statements are presented in United States dollars with all amounts rounded to the nearest thousand, except for share and per share data, or as otherwise noted. Reference herein of $ or USD is to United States dollars and C$ or CAD is to Canadian dollars.

Material accounting policies, j

Material accounting policies, judgements and estimates	3 Months Ended
	Nov. 30, 2024
Material Accounting Policies Judgements And Estimates
Material accounting policies, judgements and estimates	3. Material accounting policies, judgements and estimates The accounting policies, judgements and estimates applied in these interim condensed consolidated financial statements are consistent with those set out in Notes 3 and 4 of the Company’s annual consolidated financial statements for the year ended August 31, 2024.

Amounts receivable

Amounts receivable	3 Months Ended
	Nov. 30, 2024
Amounts Receivable
Amounts receivable	4. Amounts receivable Schedule of amounts receivables November 30, 2024 August 31, 2024 Sales tax receivable (1) $ 5,599 $ 5,144 Other 81 73 Other receivable 5,680 5,217 Less: Long-term portion (3,373 ) (3,259 ) Total amounts receivable $ 2,307 $ 1,958 (1) Sales tax receivables consist of harmonized services tax and value added tax (“VAT”) due from Canadian and Tanzanian tax authorities, respectively. Tanzanian tax regulations allow for VAT receivable to be refunded or set-off against other taxes due to the Tanzania Revenue Authority ("TRA"). The Company has historically experienced delays in receiving payment or confirmation of offset against other taxes. The Company is in communication with the TRA and there is an expectation for either cash payments or offsetting of VAT receivable against other taxes in the future. VAT which the Company does not expect to recover within the next 12 months has been classified as long-term assets. The Company held no collateral for any receivables. During the three months ended November 30, 2024, the Company recovered $ 0.9 0

Prepayments and other assets

Prepayments and other assets	3 Months Ended
	Nov. 30, 2024
Notes and other explanatory information [abstract]
Prepayments and other assets	5. Prepayments and other assets Schedule of prepayments and other assets November 30, 2024 August 31, 2024 Prepaid expenses $ 508 $ 539 Deferred financing costs (1) 707 707 Total prepayments and other assets $ 1,215 $ 1,246 (1) Consists of $0.5 million in commitment fees paid with respect to a share purchase agreement whereby the Company, at its sole discretion, has the right to sell up to $10 million of its common shares over a 36-month period and $0.2 million in deferred financing costs related to an At-the-Market Offering Agreement entered on May 12, 2023.

Inventories

Inventories	3 Months Ended
	Nov. 30, 2024
Notes and other explanatory information [abstract]
Inventories	6. Inventories Schedule of inventory November 30, 2024 August 31, 2024 Ore stockpile $ 4,491 $ 4,533 Gold in circuit 836 837 Gold doré 37 55 Total precious metals inventories 5,364 5,425 Supplies 1,170 824 Total inventories $ 6,534 $ 6,249

Mineral property, plant and equ

Mineral property, plant and equipment	3 Months Ended
	Nov. 30, 2024
Mineral Property Plant And Equipment
Mineral property, plant and equipment	7. Mineral property, plant and equipment Schedule of mineral property, plant and equipment Exploration and evaluation expenditures (1) Mineral properties Processing plant and related infrastructure Machinery and equipment (2) Right- of-use assets Other (3) Total Cost As at August 31, 2024 $ 2,281 $ 48,161 $ 29,948 $ 2,041 $ 1,721 $ 192 $ 84,344 Additions 431 1,217 1,235 127 2,352 - 5,362 As at November 30, 2024 2,712 49,378 31,183 2,168 4,073 192 89,706 Accumulated depreciation As at August 31, 2024 $ - $ 2,876 $ 2,465 $ 1,067 $ 38 $ 81 $ 6,527 Depreciation - 412 112 72 162 5 763 As at November 30, 2024 - 3,288 2,577 1,139 200 86 7,290 Net book value As at August 31, 2024 $ 2,281 $ 45,285 $ 27,483 $ 974 $ 1,683 $ 111 $ 77,817 As at November 30, 2024 2,712 46,090 28,606 1,029 3,873 106 82,416 (1) Represents exploration and evaluation expenditures related to the Anfield and Stamford Bridge deposits on the Buckreef property. (2) Includes automotive and computer equipment and software. (3) Includes leasehold improvements

Income tax

Income tax	3 Months Ended
	Nov. 30, 2024
Income Tax
Income tax	8. Income tax Income tax expense is recognized based on management’s estimate of the weighted average annual income tax rate expected for the full financial year. The maximum amount of tax losses that a business can utilize in Tanzania is 60% (2023 - 70%) of its taxable profit for the current year. The remaining 40% (2023 - 30%) of taxable profit is subject to a statutory tax rate of 30%. As a result, Buckreef’s current income tax is calculated at an effective tax rate of 12% (2023 - 9%) until Buckreef’s tax loss carryforwards are fully utilized. Tax losses in Tanzania can only be utilized by the entity to which the tax losses relate to. The carrying value of Buckreef’s Mineral Property, Plant and Equipment is higher than their tax written down values due to historical mining incentives in Tanzania and accelerated depreciation for tax purposes. The taxable temporary difference between the carrying value of Mineral Property, Plant and Equipment and its tax basis in excess of available tax loss carryforwards resulted in a deferred tax liability. For the three months ended November 30, 2024, the Company recorded income tax expense of $ 1.7 0.4 1.3 1.2 0.3 0.9

Deferred revenue

Deferred revenue	3 Months Ended
	Nov. 30, 2024
Deferred Revenue
Deferred revenue	9. Deferred revenue On August 11, 2022, the Company entered into a $ 5 1 the Company fully settled $2.5 million drawn on the first tranche of the Agreement. 0.5 1 1 0.5 Schedule of deferred revenue liability Amount As at August 31, 2024 $ 1,653 Drawdown 500 Accretion of deferred revenue (Note 21) 84 Revenue recognized (915 ) As at November 30, 2024 $ 1,322

Lease liabilities

Lease liabilities	3 Months Ended
	Nov. 30, 2024
Lease Liabilities
Lease liabilities	10. Lease liabilities Lease liabilities are measured at the discounted value of future lease payments using the lease-specific incremental borrowing rate. Lease payments are apportioned between interest expense and the reduction of the liability. Interest expense is based on the lease-specific incremental borrowing rate at the commencement date of the lease. The incremental borrowing rate differs between each category of asset, location of asset and the duration of the lease. The Company’s lease liabilities primarily comprise of leases for 13 pieces of mobile equipment for use in Buckreef’s mining operations. The carrying amounts of lease liabilities and movements during the period were: Schedule of carrying amounts of lease liabilities Amount As at August 31, 2024 $ 1,343 Additions 1,665 Accretion of lease liabilities (Note 21) 70 Lease payments (223 ) Foreign exchange (1 ) As at November 30, 2024 $ 2,854 Schedule of lease liabilities November 30, 2024 August 31, 2024 Current portion of lease liabilities $ 903 $ 401 Lease liabilities 1,951 942 Balance at end of period $ 2,854 $ 1,343 The following amounts are recognized in the statement of income and comprehensive income: Schedule of statement of income and comprehensive income For the three months ended Nov 30, 2024 2023 Depreciation expense for right-of-use assets $ 162 $ 11 Accretion of lease liabilities 70 1 Total amount $ 232 $ 12 As at November 30, 2024, the Company was committed to a lease for one additional piece of equipment which had not yet commenced with payments totaling $ 0.7 As at November 30, 2024, the Company had the following lease commitments: Schedule of lease commitments Amount Not later than one month $ 124 Later than one month and not later than three months 201 Later than three months and not later than one year 920 Later than one year and not later than five years 2,177 Total undiscounted lease commitments $ 3,422 As at November 30, 2024, the carrying value of right-of-use assets amounted to $ 3.9 1.7

Derivative financial instrument

Derivative financial instrument liabilities	3 Months Ended
	Nov. 30, 2024
Derivative Financial Instrument Liabilities
Derivative financial instrument liabilities	11. Derivative financial instrument liabilities Schedule of derivative financial instrument liabilities November 30, 2024 August 31, 2024 Derivative warrant liabilities $ 1,454 $ 2,273 Total derivative financial instrument liabilities $ 1,454 $ 2,273 a) Derivative warrant liabilities Schedule of derivative warrant liabilities Amount As at August 31, 2024 $ 2,273 Change in fair value (819 ) As at November 30, 2024 $ 1,454 Derivative warrant liabilities of $ 1.5 0.8 0.2 Fair values of derivative warrant liabilities were calculated using the Black-Scholes Option Pricing Model with the following assumptions: Schedule of assumptions fair value of derivative warrant liabilities November 30, 2024 August 31, 2024 Share price $ 0.36 $ 0.39 Risk-free interest rate 4.08 4.22 3.82 4.13 Dividend yield 0 0 Expected volatility 43 45 47 49 Remaining term (in years) 1.2 2.2 1.5 2.4 The fair value is classified as level 3 as expected volatilities is determined using adjusted historical volatilities and were therefore not an observable input. Sensitivity analysis If expected volatility, the significant unobservable input, had been higher or lower by 10% and all other variables were held constant, net income and net assets for the three months ended November 30, 2024 would increase or decrease by: Schedule of net loss and net assets November 30, 2024 10% change in expected volatilities Increase Decrease (Loss) income $ (493 ) $ 443

Earnings (loss) per share

Earnings (loss) per share	3 Months Ended
	Nov. 30, 2024
Notes and other explanatory information [abstract]
Earnings (loss) per share	12. Earnings (loss) per share Schedule of earnings (loss) per share Three months ended November 30, 2024 2023 Net income (loss) attributable to shareholders $ 981 $ (966 ) Weighted average number of common shares for basic EPS (1) 291,668,469 285,283,429 Effect of dilutive stock options, warrants, RSUs and share awards 1,826,542 - Weighted average number of common shares for diluted EPS (1) 293,495,011 285,283,429 (1) The weighted average number of common shares for basic and diluted EPS include 11.0 million gross number of vested, but unissued, common shares relating to common share awards. For the three months ended November 30, 2024, the weighted average number of common shares for diluted EPS excluded 10.5 36.2 15.4 2.8 4.6 39.0

Share-based payments reserve

Share-based payments reserve	3 Months Ended
	Nov. 30, 2024
Notes and other explanatory information [abstract]
Share-based payments reserve	13. Share-based payments reserve Share-based compensation expense for the three months ended November 30, 2024 totaled $ 0.2 0.9 As at November 30, 2024, the Company had 6,942,109 5,997,632 a) Stock options Canadian Dollars denominated stock options Schedule of continuity of outstanding stock options Number of stock options Weighted average exercise price per share Balance – August 31, 2024 4,986,000 CAD $ 0.41 Options exercised (1) (562,000 ) CAD $ 0.42 Balance – November 30, 2024 4,424,000 CAD $ 0.41 (1) The weighted average share price at the time of the option exercise was C$0.53. Options to purchase common shares carry exercise prices and terms to maturity as follows: Schedule of options to purchase common shares carry exercise prices and terms to maturity Remaining Number of options Expiry contractual Exercise price Outstanding Exercisable Date life (years) C$ 0.40 2,259,000 2,259,000 October 11, 2026 1.9 C$ 0.43 2,065,000 2,065,000 September 29, 2026 1.8 C$ 0.35 100,000 100,000 January 2, 2027 2.1 C$ 0.41 (1) 4,424,000 4,424,000 1.9 (1) (1) Total represents weighted average. US Dollars denominated stock options Schedule of outstanding stock options Number of stock options Weighted average exercise price per share Balance – November 30, 2024 and August 31, 2024 10,450,000 $ 0.49 Options to purchase common shares carry exercise prices and terms to maturity as follows: Schedule of options to purchase common shares exercise prices Remaining Number of options Expiry contractual Exercise price Outstanding Exercisable Date life (years) USD $ 0.50 7,375,000 4,425,000 August 17, 2027 2.7 USD $ 0.45 3,075,000 1,230,000 August 28, 2028 3.7 USD $ 0.49 (1) 10,450,000 5,655,000 3.0 (1) (1) Total represents weighted average. For the three months ended November 30, 2024, share-based compensation expense related to stock options totaled $ 0.1 0.2 b) Restricted Share Units: The following table sets out activity with respect to outstanding RSUs: Schedule of restricted stock outstanding Number of RSUs Balance – November 30, 2024 and August 31, 2024 1,498,385 For the three months ended November 30, 2024, share-based payment expenses related to RSUs totaled $ 0.1 0.5

Warrants reserve

Warrants reserve	3 Months Ended
	Nov. 30, 2024
Warrants Reserve
Warrants reserve	14. Warrants reserve Schedule of warrants reserve Number of warrants Weighted average exercise price per share Weighted average remaining contractual life (years) Balance – August 31, 2024 36,190,769 $0.62 1.9 Balance – November 30, 2024 36,190,769 $0.62 1.7 As at November 30, 2024, the following warrants were outstanding: Schedule of warrants outstanding Number of Exercise price Expiry date Private placement financing warrants - February 11, 2021 16,461,539 $0.80 February 11, 2026 Private placement financing broker warrants - February 11, 2021 1,152,307 $0.80 February 11, 2026 Private placement financing warrants - January 26, 2022 17,948,718 $0.44 January 26, 2027 Private placement financing placement agent warrants - January 26, 2022 628,205 $0.44 January 26, 2027 Balance – November 30, 2024 36,190,769 $ 0.62 (1) (1) Total represents weighted average.

Non-controlling interest

Non-controlling interest	3 Months Ended
	Nov. 30, 2024
Notes and other explanatory information [abstract]
Non-controlling interest	15. Non-controlling interest Summarized financial information for Buckreef is disclosed below: Schedule of summarized financial information Three months ended November 30, Income Statement 2024 2023 Revenue $ 12,528 $ 9,404 Depreciation 906 484 Accretion expense 188 140 Income tax expense 1,693 1,191 Comprehensive income for the period 2,568 2,061 Statement of Financial Position November 30, 2024 August 31, 2024 Current assets $ 10,746 $ 11,297 Non-current assets 83,681 78,952 Current liabilities (17,057 ) (16,973 ) Non-current liabilities (13,863 ) (11,528 ) Advances from parent, net (29,371 ) (30,210 ) Three months ended November 30, Statement of Cash Flows 2024 2023 Cash provided by operating activities $ 3,572 $ 6,110 Cash used in investing activities (3,675 ) (4,057 ) Cash used in financing activities (1,090 ) (1,089 )

Related party transactions

Related party transactions	3 Months Ended
	Nov. 30, 2024
Related Party Transactions
Related party transactions	16. Related party transactions Related parties include the Board of Directors and officers, extended relatives and enterprises that are controlled by these individuals as well as certain consultants performing similar functions. Remuneration of Directors and key management personnel of the Company was as follows: Schedule of related parties compensation Three months ended Directors and key management personnel 2024 2023 Remuneration $ 366 $ 436 Share-based compensation expense 93 693 Total directors and key management personnel $ 459 $ 1,129 During the three months ended November 30, 2024, $ 0.1 0.2 0 0.3 During the three months ended November 30, 2024, 0 0.2

General and administrative expe

General and administrative expenses	3 Months Ended
	Nov. 30, 2024
Notes and other explanatory information [abstract]
General and administrative expenses	17. General and administrative expenses Schedule of general and administrative expense Three months ended 2024 2023 Directors’ fees (Note 16) $ 64 $ 60 Insurance 61 85 Office and general 60 67 Shareholder information 151 158 Professional fees 169 189 Salaries and benefits (Note 16) 477 558 Consulting 215 177 Share-based compensation expense (Notes 13 and 16) 156 810 Travel and accommodation 52 78 Depreciation 15 13 Other 5 16 Total general and administrative expenses $ 1,425 $ 2,211

Financial instruments

Financial instruments	3 Months Ended
	Nov. 30, 2024
Notes and other explanatory information [abstract]
Financial instruments	18. Financial instruments Fair value of financial instruments The following table sets out the classification of the Company’s financial instruments as at November 30, 2024 and August 31, 2024: Schedule of financial instruments November 30, 2024 August 31, 2024 Financial Assets Measured at amortized cost Amounts receivable $ 2,307 $ 1,958 Measured at fair value through profit or loss Cash 6,787 8,331 Financial Liabilities Measured at amortized cost Amounts payables and accrued liabilities 15,876 15,545 Measured at fair value through profit or loss Derivative financial instrument liabilities 1,454 2,273 Cash, derivative warrant liabilities are classified as measured at fair value through profit and loss. Amounts receivable and amounts payable are classified as measured at amortized cost. The carrying value of the Company’s amounts receivable and amounts payable approximate their fair value due to the relatively short-term nature of these instruments. Fair value estimates are made at a specific point in time based on relevant market information and information about financial instruments. These estimates are subject to and involve uncertainties and matters of significant judgment, and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates. The Company classifies its financial instruments carried at fair value according to a three-level hierarchy that reflects the significance of the inputs used in making the fair value measurements. The three levels of fair value hierarchy, giving the highest priority to Level 1 inputs and the lowest priority to Level 3 inputs, are as follows: · Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities; · Level 2 – Inputs other than quoted prices that are observable for assets and liabilities, either directly or indirectly; and · Level 3 – Inputs for assets or liabilities that are not based on observable market data. As at November 30, 2024 and August 31, 2024, cash was classified as Level 1 and derivative financial instruments (Note 11) were classified as Level 3 under the fair value hierarchy.

Segmented information

Segmented information	3 Months Ended
	Nov. 30, 2024
Segmented Information
Segmented information	19. Segmented information Operating segments The Company’s Chief Operating Decision Maker, its Chief Executive Officer, reviews the operating results, assesses the performance and makes capital allocation decisions of the Company viewed as a single operating segment engaged in mineral exploration and development in Tanzania. All amounts disclosed in the interim condensed consolidated financial statements represent this single reporting segment. The Company’s corporate division only earns interest revenue that is considered incidental to the activities of the Company and does not meet the definition of an operating segment as defined in IFRS 8, Operating Segments Geographic segments The Company is in the business of mineral exploration and production in Tanzania. Information regarding the Company’s geographic locations are as follows: Schedule of revenue Three months ended Revenue 2024 2023 Tanzania $ 12,528 $ 9,404 Total revenue $ 12,528 $ 9,404 During the three months ended November 30, 2024, the Company generated 93 90 11.6 8.5 Schedule of non-current assets Non-current assets November 30, 2024 August 31, 2024 Canada $ 30 $ 36 Tanzania 85,759 81,040 Total non-current assets $ 85,789 $ 81,076

Commitments and contingencies

Commitments and contingencies	3 Months Ended
	Nov. 30, 2024
Notes and other explanatory information [abstract]
Commitments and contingencies	20. Commitments and contingencies Commitments: In order to maintain its existing mining and exploration licenses, the Company is required to pay annual license fees. As at November 30, 2024 and August 31, 2024, these licenses remained in good standing and the Company is up to date on its license payments. Contingencies: The Company is involved in litigation and disputes arising in the normal course of operations. Management is of the opinion that the outcome of any potential litigation will not have a material adverse impact on the Company’s financial position or results of operations. Accordingly, no provisions for the settlement of outstanding litigation and potential claims have been accrued as at November 30, 2024 and August 31, 2024.

Non-cash items

Non-cash items	3 Months Ended
	Nov. 30, 2024
Non-cash Items
Non-cash items	21. Non-cash items Schedule of non-cash items Three months ended 2024 2023 Depreciation $ 921 $ 497 Change in fair value of derivative financial instruments (Note 11) (819 ) (199 ) Share-based compensation expense (Note 13) 189 875 Accretion of provision for reclamation 36 27 Deferred income tax expense (Note 8) 1,291 899 Accretion of lease liabilities (Note 10) 70 1 Deferred revenue (Note 9) (415 ) 578 Accretion of deferred revenue (Note 9) 84 112 Foreign exchange losses 190 165 Total non-cash items $ 1,547 $ 2,955 For the three months ended November 30, 2024, an increase in amounts payable and accrued liabilities related to purchase of mineral property, plant and equipment was $ 0.1 0.6

Amounts receivable (Tables)

Amounts receivable (Tables)	3 Months Ended
	Nov. 30, 2024
Amounts Receivable
Schedule of amounts receivables	Schedule of amounts receivables November 30, 2024 August 31, 2024 Sales tax receivable (1) $ 5,599 $ 5,144 Other 81 73 Other receivable 5,680 5,217 Less: Long-term portion (3,373 ) (3,259 ) Total amounts receivable $ 2,307 $ 1,958 (1) Sales tax receivables consist of harmonized services tax and value added tax (“VAT”) due from Canadian and Tanzanian tax authorities, respectively. Tanzanian tax regulations allow for VAT receivable to be refunded or set-off against other taxes due to the Tanzania Revenue Authority ("TRA"). The Company has historically experienced delays in receiving payment or confirmation of offset against other taxes. The Company is in communication with the TRA and there is an expectation for either cash payments or offsetting of VAT receivable against other taxes in the future. VAT which the Company does not expect to recover within the next 12 months has been classified as long-term assets.

Prepayments and other assets (T

Prepayments and other assets (Tables)	3 Months Ended
	Nov. 30, 2024
Notes and other explanatory information [abstract]
Schedule of prepayments and other assets	Schedule of prepayments and other assets November 30, 2024 August 31, 2024 Prepaid expenses $ 508 $ 539 Deferred financing costs (1) 707 707 Total prepayments and other assets $ 1,215 $ 1,246 (1) Consists of $0.5 million in commitment fees paid with respect to a share purchase agreement whereby the Company, at its sole discretion, has the right to sell up to $10 million of its common shares over a 36-month period and $0.2 million in deferred financing costs related to an At-the-Market Offering Agreement entered on May 12, 2023.

Inventories (Tables)

Inventories (Tables)	3 Months Ended
	Nov. 30, 2024
Notes and other explanatory information [abstract]
Schedule of inventory	Schedule of inventory November 30, 2024 August 31, 2024 Ore stockpile $ 4,491 $ 4,533 Gold in circuit 836 837 Gold doré 37 55 Total precious metals inventories 5,364 5,425 Supplies 1,170 824 Total inventories $ 6,534 $ 6,249

Mineral property, plant and e_2

Mineral property, plant and equipment (Tables)	3 Months Ended
	Nov. 30, 2024
Mineral Property Plant And Equipment
Schedule of mineral property, plant and equipment	Schedule of mineral property, plant and equipment Exploration and evaluation expenditures (1) Mineral properties Processing plant and related infrastructure Machinery and equipment (2) Right- of-use assets Other (3) Total Cost As at August 31, 2024 $ 2,281 $ 48,161 $ 29,948 $ 2,041 $ 1,721 $ 192 $ 84,344 Additions 431 1,217 1,235 127 2,352 - 5,362 As at November 30, 2024 2,712 49,378 31,183 2,168 4,073 192 89,706 Accumulated depreciation As at August 31, 2024 $ - $ 2,876 $ 2,465 $ 1,067 $ 38 $ 81 $ 6,527 Depreciation - 412 112 72 162 5 763 As at November 30, 2024 - 3,288 2,577 1,139 200 86 7,290 Net book value As at August 31, 2024 $ 2,281 $ 45,285 $ 27,483 $ 974 $ 1,683 $ 111 $ 77,817 As at November 30, 2024 2,712 46,090 28,606 1,029 3,873 106 82,416 (1) Represents exploration and evaluation expenditures related to the Anfield and Stamford Bridge deposits on the Buckreef property. (2) Includes automotive and computer equipment and software. (3) Includes leasehold improvements

Deferred revenue (Tables)

Deferred revenue (Tables)	3 Months Ended
	Nov. 30, 2024
Deferred Revenue
Schedule of deferred revenue liability	Schedule of deferred revenue liability Amount As at August 31, 2024 $ 1,653 Drawdown 500 Accretion of deferred revenue (Note 21) 84 Revenue recognized (915 ) As at November 30, 2024 $ 1,322

Lease liabilities (Tables)

Lease liabilities (Tables)	3 Months Ended
	Nov. 30, 2024
Lease Liabilities
Schedule of carrying amounts of lease liabilities	Schedule of carrying amounts of lease liabilities Amount As at August 31, 2024 $ 1,343 Additions 1,665 Accretion of lease liabilities (Note 21) 70 Lease payments (223 ) Foreign exchange (1 ) As at November 30, 2024 $ 2,854
Schedule of lease liabilities	Schedule of lease liabilities November 30, 2024 August 31, 2024 Current portion of lease liabilities $ 903 $ 401 Lease liabilities 1,951 942 Balance at end of period $ 2,854 $ 1,343
Schedule of statement of income and comprehensive income	Schedule of statement of income and comprehensive income For the three months ended Nov 30, 2024 2023 Depreciation expense for right-of-use assets $ 162 $ 11 Accretion of lease liabilities 70 1 Total amount $ 232 $ 12
Schedule of lease commitments	Schedule of lease commitments Amount Not later than one month $ 124 Later than one month and not later than three months 201 Later than three months and not later than one year 920 Later than one year and not later than five years 2,177 Total undiscounted lease commitments $ 3,422

Derivative financial instrume_2

Derivative financial instrument liabilities (Tables)	3 Months Ended
	Nov. 30, 2024
Derivative Financial Instrument Liabilities
Schedule of derivative financial instrument liabilities	Schedule of derivative financial instrument liabilities November 30, 2024 August 31, 2024 Derivative warrant liabilities $ 1,454 $ 2,273 Total derivative financial instrument liabilities $ 1,454 $ 2,273
Schedule of derivative warrant liabilities	Schedule of derivative warrant liabilities Amount As at August 31, 2024 $ 2,273 Change in fair value (819 ) As at November 30, 2024 $ 1,454
Schedule of assumptions fair value of derivative warrant liabilities	Schedule of assumptions fair value of derivative warrant liabilities November 30, 2024 August 31, 2024 Share price $ 0.36 $ 0.39 Risk-free interest rate 4.08 4.22 3.82 4.13 Dividend yield 0 0 Expected volatility 43 45 47 49 Remaining term (in years) 1.2 2.2 1.5 2.4
Schedule of net loss and net assets	Schedule of net loss and net assets November 30, 2024 10% change in expected volatilities Increase Decrease (Loss) income $ (493 ) $ 443

Earnings (loss) per share (Tabl

Earnings (loss) per share (Tables)	3 Months Ended
	Nov. 30, 2024
Notes and other explanatory information [abstract]
Schedule of earnings (loss) per share	Schedule of earnings (loss) per share Three months ended November 30, 2024 2023 Net income (loss) attributable to shareholders $ 981 $ (966 ) Weighted average number of common shares for basic EPS (1) 291,668,469 285,283,429 Effect of dilutive stock options, warrants, RSUs and share awards 1,826,542 - Weighted average number of common shares for diluted EPS (1) 293,495,011 285,283,429 (1) The weighted average number of common shares for basic and diluted EPS include 11.0 million gross number of vested, but unissued, common shares relating to common share awards.

Share-based payments reserve (T

Share-based payments reserve (Tables)	3 Months Ended
	Nov. 30, 2024
IfrsStatementLineItems [Line Items]
Schedule of continuity of outstanding stock options	Schedule of continuity of outstanding stock options Number of stock options Weighted average exercise price per share Balance – August 31, 2024 4,986,000 CAD $ 0.41 Options exercised (1) (562,000 ) CAD $ 0.42 Balance – November 30, 2024 4,424,000 CAD $ 0.41 (1) The weighted average share price at the time of the option exercise was C$0.53.
Schedule of restricted stock outstanding	Schedule of restricted stock outstanding Number of RSUs Balance – November 30, 2024 and August 31, 2024 1,498,385
Stock Options [Member]
IfrsStatementLineItems [Line Items]
Schedule of options to purchase common shares exercise prices	Schedule of options to purchase common shares carry exercise prices and terms to maturity Remaining Number of options Expiry contractual Exercise price Outstanding Exercisable Date life (years) C$ 0.40 2,259,000 2,259,000 October 11, 2026 1.9 C$ 0.43 2,065,000 2,065,000 September 29, 2026 1.8 C$ 0.35 100,000 100,000 January 2, 2027 2.1 C$ 0.41 (1) 4,424,000 4,424,000 1.9 (1) (1) Total represents weighted average.
Stock Options 1 [Member]
IfrsStatementLineItems [Line Items]
Schedule of options to purchase common shares exercise prices	Schedule of options to purchase common shares exercise prices Remaining Number of options Expiry contractual Exercise price Outstanding Exercisable Date life (years) USD $ 0.50 7,375,000 4,425,000 August 17, 2027 2.7 USD $ 0.45 3,075,000 1,230,000 August 28, 2028 3.7 USD $ 0.49 (1) 10,450,000 5,655,000 3.0 (1) (1) Total represents weighted average.
Schedule of outstanding stock options	Schedule of outstanding stock options Number of stock options Weighted average exercise price per share Balance – November 30, 2024 and August 31, 2024 10,450,000 $ 0.49

Warrants reserve (Tables)

Warrants reserve (Tables)	3 Months Ended
	Nov. 30, 2024
Warrants Reserve
Schedule of warrants reserve	Schedule of warrants reserve Number of warrants Weighted average exercise price per share Weighted average remaining contractual life (years) Balance – August 31, 2024 36,190,769 $0.62 1.9 Balance – November 30, 2024 36,190,769 $0.62 1.7
Schedule of warrants outstanding	Schedule of warrants outstanding Number of Exercise price Expiry date Private placement financing warrants - February 11, 2021 16,461,539 $0.80 February 11, 2026 Private placement financing broker warrants - February 11, 2021 1,152,307 $0.80 February 11, 2026 Private placement financing warrants - January 26, 2022 17,948,718 $0.44 January 26, 2027 Private placement financing placement agent warrants - January 26, 2022 628,205 $0.44 January 26, 2027 Balance – November 30, 2024 36,190,769 $ 0.62 (1) (1) Total represents weighted average.

Non-controlling interest (Table

Non-controlling interest (Tables)	3 Months Ended
	Nov. 30, 2024
Notes and other explanatory information [abstract]
Schedule of summarized financial information	Schedule of summarized financial information Three months ended November 30, Income Statement 2024 2023 Revenue $ 12,528 $ 9,404 Depreciation 906 484 Accretion expense 188 140 Income tax expense 1,693 1,191 Comprehensive income for the period 2,568 2,061 Statement of Financial Position November 30, 2024 August 31, 2024 Current assets $ 10,746 $ 11,297 Non-current assets 83,681 78,952 Current liabilities (17,057 ) (16,973 ) Non-current liabilities (13,863 ) (11,528 ) Advances from parent, net (29,371 ) (30,210 ) Three months ended November 30, Statement of Cash Flows 2024 2023 Cash provided by operating activities $ 3,572 $ 6,110 Cash used in investing activities (3,675 ) (4,057 ) Cash used in financing activities (1,090 ) (1,089 )

Related party transactions (Tab

Related party transactions (Tables)	3 Months Ended
	Nov. 30, 2024
Related Party Transactions
Schedule of related parties compensation	Schedule of related parties compensation Three months ended Directors and key management personnel 2024 2023 Remuneration $ 366 $ 436 Share-based compensation expense 93 693 Total directors and key management personnel $ 459 $ 1,129

General and administrative ex_2

General and administrative expenses (Tables)	3 Months Ended
	Nov. 30, 2024
Notes and other explanatory information [abstract]
Schedule of general and administrative expense	Schedule of general and administrative expense Three months ended 2024 2023 Directors’ fees (Note 16) $ 64 $ 60 Insurance 61 85 Office and general 60 67 Shareholder information 151 158 Professional fees 169 189 Salaries and benefits (Note 16) 477 558 Consulting 215 177 Share-based compensation expense (Notes 13 and 16) 156 810 Travel and accommodation 52 78 Depreciation 15 13 Other 5 16 Total general and administrative expenses $ 1,425 $ 2,211

Financial instruments (Tables)

Financial instruments (Tables)	3 Months Ended
	Nov. 30, 2024
Notes and other explanatory information [abstract]
Schedule of financial instruments	Schedule of financial instruments November 30, 2024 August 31, 2024 Financial Assets Measured at amortized cost Amounts receivable $ 2,307 $ 1,958 Measured at fair value through profit or loss Cash 6,787 8,331 Financial Liabilities Measured at amortized cost Amounts payables and accrued liabilities 15,876 15,545 Measured at fair value through profit or loss Derivative financial instrument liabilities 1,454 2,273

Segmented information (Tables)

Segmented information (Tables)	3 Months Ended
	Nov. 30, 2024
Segmented Information
Schedule of revenue	Schedule of revenue Three months ended Revenue 2024 2023 Tanzania $ 12,528 $ 9,404 Total revenue $ 12,528 $ 9,404
Schedule of non-current assets	Schedule of non-current assets Non-current assets November 30, 2024 August 31, 2024 Canada $ 30 $ 36 Tanzania 85,759 81,040 Total non-current assets $ 85,789 $ 81,076

Non-cash items (Tables)

Non-cash items (Tables)	3 Months Ended
	Nov. 30, 2024
Non-cash Items
Schedule of non-cash items	Schedule of non-cash items Three months ended 2024 2023 Depreciation $ 921 $ 497 Change in fair value of derivative financial instruments (Note 11) (819 ) (199 ) Share-based compensation expense (Note 13) 189 875 Accretion of provision for reclamation 36 27 Deferred income tax expense (Note 8) 1,291 899 Accretion of lease liabilities (Note 10) 70 1 Deferred revenue (Note 9) (415 ) 578 Accretion of deferred revenue (Note 9) 84 112 Foreign exchange losses 190 165 Total non-cash items $ 1,547 $ 2,955 For the three months ended November 30, 2024, an increase in amounts payable and accrued liabilities related to purchase of mineral property, plant and equipment was $ 0.1 0.6

Amounts receivable (Details)

Amounts receivable (Details) - USD ($) $ in Thousands		Nov. 30, 2024	Aug. 31, 2024
Amounts Receivable
Sales tax receivable	[1]	$ 5,599	$ 5,144
Other		81	73
Other receivable		5,680	5,217
Less: Long-term portion		(3,373)	(3,259)
Total amounts receivable		$ 2,307	$ 1,958
[1]Sales tax receivables consist of harmonized services tax and value added tax (“VAT”) due from Canadian and Tanzanian tax authorities, respectively. Tanzanian tax regulations allow for VAT receivable to be refunded or set-off against other taxes due to the Tanzania Revenue Authority ("TRA"). The Company has historically experienced delays in receiving payment or confirmation of offset against other taxes. The Company is in communication with the TRA and there is an expectation for either cash payments or offsetting of VAT receivable against other taxes in the future. VAT which the Company does not expect to recover within the next 12 months has been classified as long-term assets.

Amounts receivable (Details Nar

Amounts receivable (Details Narrative) - USD ($) $ in Millions	3 Months Ended
	Nov. 30, 2024	Nov. 30, 2023
TRA [Member]
IfrsStatementLineItems [Line Items]
VAT refunds	$ 0.9	$ 0

Prepayments and other assets (D

Prepayments and other assets (Details) - USD ($) $ in Thousands		Nov. 30, 2024	Aug. 31, 2024
Notes and other explanatory information [abstract]
Prepaid expenses		$ 508	$ 539
Deferred financing costs	[1]	707	707
Total prepayments and other assets		$ 1,215	$ 1,246
[1]Consists of $0.5 million in commitment fees paid with respect to a share purchase agreement whereby the Company, at its sole discretion, has the right to sell up to $10 million of its common shares over a 36-month period and $0.2 million in deferred financing costs related to an At-the-Market Offering Agreement entered on May 12, 2023.

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Nov. 30, 2024	Aug. 31, 2024
Notes and other explanatory information [abstract]
Ore stockpile	$ 4,491	$ 4,533
Gold in circuit	836	837
Gold doré	37	55
Total precious metals inventories	5,364	5,425
Supplies	1,170	824
Total inventories	$ 6,534	$ 6,249

Mineral property, plant and e_3

Mineral property, plant and equipment (Details) - USD ($) $ in Thousands		3 Months Ended
		Nov. 30, 2024	Aug. 31, 2024
IfrsStatementLineItems [Line Items]
Mineral property, plant and equipment		$ 82,416	$ 77,817
Exploration And Evaluation Expenditures [Member]
IfrsStatementLineItems [Line Items]
Mineral property, plant and equipment	[1]	2,712	2,281
Mining property [member]
IfrsStatementLineItems [Line Items]
Mineral property, plant and equipment		46,090	45,285
Processing Plant And Related Infrastructure [Member]
IfrsStatementLineItems [Line Items]
Mineral property, plant and equipment		28,606	27,483
Machinery [member]
IfrsStatementLineItems [Line Items]
Mineral property, plant and equipment	[2]	1,029	974
Rightofuse Asset [Member]
IfrsStatementLineItems [Line Items]
Mineral property, plant and equipment	[3]	3,873	1,683
Other [Member]
IfrsStatementLineItems [Line Items]
Mineral property, plant and equipment	[3]	106	111
Total [Member]
IfrsStatementLineItems [Line Items]
Mineral property, plant and equipment		82,416	$ 77,817
Gross carrying amount [member]
IfrsStatementLineItems [Line Items]
Mineral property, plant and equipment		84,344
Additions other than through business combinations, property, plant and equipment		5,362
Mineral property, plant and equipment		89,706
Gross carrying amount [member] | Exploration And Evaluation Expenditures [Member]
IfrsStatementLineItems [Line Items]
Mineral property, plant and equipment	[1]	2,281
Additions other than through business combinations, property, plant and equipment	[1]	431
Mineral property, plant and equipment	[1]	2,712
Gross carrying amount [member] | Mining property [member]
IfrsStatementLineItems [Line Items]
Mineral property, plant and equipment		48,161
Additions other than through business combinations, property, plant and equipment		1,217
Mineral property, plant and equipment		49,378
Gross carrying amount [member] | Processing Plant And Related Infrastructure [Member]
IfrsStatementLineItems [Line Items]
Mineral property, plant and equipment		29,948
Additions other than through business combinations, property, plant and equipment		1,235
Mineral property, plant and equipment		31,183
Gross carrying amount [member] | Machinery [member]
IfrsStatementLineItems [Line Items]
Mineral property, plant and equipment	[2]	2,041
Additions other than through business combinations, property, plant and equipment	[2]	127
Mineral property, plant and equipment	[2]	2,168
Gross carrying amount [member] | Rightofuse Asset [Member]
IfrsStatementLineItems [Line Items]
Mineral property, plant and equipment	[3]	1,721
Additions other than through business combinations, property, plant and equipment	[3]	2,352
Mineral property, plant and equipment	[3]	4,073
Gross carrying amount [member] | Other [Member]
IfrsStatementLineItems [Line Items]
Mineral property, plant and equipment	[3]	192
Additions other than through business combinations, property, plant and equipment	[3]
Mineral property, plant and equipment	[3]	192
Accumulated depreciation and amortisation [member]
IfrsStatementLineItems [Line Items]
Mineral property, plant and equipment		6,527
Additions other than through business combinations, property, plant and equipment		763
Mineral property, plant and equipment		7,290
Accumulated depreciation and amortisation [member] | Exploration And Evaluation Expenditures [Member]
IfrsStatementLineItems [Line Items]
Mineral property, plant and equipment	[1]
Additions other than through business combinations, property, plant and equipment	[1]
Mineral property, plant and equipment	[1]
Accumulated depreciation and amortisation [member] | Mining property [member]
IfrsStatementLineItems [Line Items]
Mineral property, plant and equipment		2,876
Additions other than through business combinations, property, plant and equipment		412
Mineral property, plant and equipment		3,288
Accumulated depreciation and amortisation [member] | Processing Plant And Related Infrastructure [Member]
IfrsStatementLineItems [Line Items]
Mineral property, plant and equipment		2,465
Additions other than through business combinations, property, plant and equipment		112
Mineral property, plant and equipment		2,577
Accumulated depreciation and amortisation [member] | Machinery [member]
IfrsStatementLineItems [Line Items]
Mineral property, plant and equipment	[2]	1,067
Additions other than through business combinations, property, plant and equipment	[2]	72
Mineral property, plant and equipment	[2]	1,139
Accumulated depreciation and amortisation [member] | Rightofuse Asset [Member]
IfrsStatementLineItems [Line Items]
Mineral property, plant and equipment	[3]	38
Additions other than through business combinations, property, plant and equipment	[3]	162
Mineral property, plant and equipment	[3]	200
Accumulated depreciation and amortisation [member] | Other [Member]
IfrsStatementLineItems [Line Items]
Mineral property, plant and equipment	[3]	81
Additions other than through business combinations, property, plant and equipment	[3]	5
Mineral property, plant and equipment	[3]	$ 86
[1]Represents exploration and evaluation expenditures related to the Anfield and Stamford Bridge deposits on the Buckreef property.[2]Includes automotive and computer equipment and software.[3]Includes leasehold improvements

Income tax (Details Narrative)

Income tax (Details Narrative) - USD ($) $ in Millions	3 Months Ended
	Nov. 30, 2024	Nov. 30, 2023
Income Tax
Income tax expenses	$ 1.7	$ 1.2
Current income tax expense	0.4	0.3
Deferred income tax expense	$ 1.3	$ 0.9

Deferred revenue (Details)

Deferred revenue (Details) $ in Thousands	3 Months Ended
	Nov. 30, 2024 USD ($)
Deferred Revenue
Deferred revenue, beginning	$ 1,653
Drawdown	500
Accretion of deferred revenue	84
Revenue recognized	(915)
Deferred revenue, ending	$ 1,322

Deferred revenue (Details Narra

Deferred revenue (Details Narrative) - USD ($) $ in Millions	3 Months Ended
	Nov. 30, 2023	Oct. 30, 2024	May 06, 2024	Nov. 29, 2023	Sep. 26, 2023	Jul. 11, 2023	Aug. 11, 2022
IfrsStatementLineItems [Line Items]
Deferred revenue undrawn		$ 0.5	$ 1	$ 1	$ 0.5	$ 1
Deferred revenue description	the Company fully settled $2.5 million drawn on the first tranche of the Agreement.
Purchase Agreement [Member]
IfrsStatementLineItems [Line Items]
Prepaid gold ore							$ 5

Lease liabilities (Details)

Lease liabilities (Details) $ in Thousands	3 Months Ended
	Nov. 30, 2024 USD ($)
Lease Liabilities
lease liabilities, beginning	$ 1,343
Additions	1,665
Accretion of lease liabilities	70
Lease payments	(223)
Foreign exchange	(1)
lease liabilities, ending	$ 2,854

Lease liabilities (Details 1)

Lease liabilities (Details 1) - USD ($) $ in Thousands	Nov. 30, 2024	Aug. 31, 2024
Lease Liabilities
Current portion of lease liabilities	$ 903	$ 401
Lease liabilities	1,951	942
Balance at end of period	$ 2,854	$ 1,343

Lease liabilities (Details 2)

Lease liabilities (Details 2) - USD ($) $ in Thousands	3 Months Ended
	Nov. 30, 2024	Nov. 30, 2023
Lease Liabilities
Depreciation expense for right-of-use assets	$ 162	$ 11
Accretion of lease liabilities	70	1
Total amount	$ 232	$ 12

Lease liabilities (Details 3)

Lease liabilities (Details 3) $ in Thousands	Nov. 30, 2024 USD ($)
Lease Liabilities
Not later than one month	$ 124
Later than one month and not later than three months	201
Later than three months and not later than one year	920
Later than one year and not later than five years	2,177
Total undiscounted lease commitments	$ 3,422

Lease liabilities (Details Narr

Lease liabilities (Details Narrative) - USD ($) $ in Millions	Nov. 30, 2024	Aug. 31, 2024
Lease Liabilities
Payments to additional piece of equipment	$ 0.7
Right-of-use assets	$ 3.9	$ 1.7

Derivative financial instrume_3

Derivative financial instrument liabilities (Details) - USD ($) $ in Thousands	Nov. 30, 2024	Aug. 31, 2024
Derivative Financial Instrument Liabilities
Derivative warrant liabilities	$ 1,454	$ 2,273
Total derivative financial instrument liabilities	$ 1,454	$ 2,273

Derivative financial instrume_4

Derivative financial instrument liabilities (Details 1) - Derivative Warrant Liabilities [Member] $ in Thousands	3 Months Ended
	Nov. 30, 2024 USD ($)
IfrsStatementLineItems [Line Items]
Beginning balance at derivative warrant liabilities	$ 2,273
Change in fair value	(819)
Ending balance at derivative warrant liabilities	$ 1,454

Derivative financial instrume_5

Derivative financial instrument liabilities (Details 2) - Derivative Warrant Liabilities [Member] - $ / shares	3 Months Ended	12 Months Ended
	Nov. 30, 2024	Aug. 31, 2024
IfrsStatementLineItems [Line Items]
Share price	$ 0.36	$ 0.39
Dividend yield	0%	0%
Bottom of range [member]
IfrsStatementLineItems [Line Items]
Risk-free interest rate	4.08%	3.82%
Expected volatility	43%	47%
Remaining term (in years)	1 year 2 months 12 days	1 year 6 months
Top of range [member]
IfrsStatementLineItems [Line Items]
Risk-free interest rate	4.22%	4.13%
Expected volatility	45%	49%
Remaining term (in years)	2 years 2 months 12 days	2 years 4 months 24 days

Derivative financial instrume_6

Derivative financial instrument liabilities (Details 3) $ in Thousands	3 Months Ended
	Nov. 30, 2024 USD ($)
Derivative Financial Instrument Liabilities
Increase loss income	$ (493)
Decrease loss income	$ 443

Derivative financial instrume_7

Derivative financial instrument liabilities (Details Narrative) - USD ($) $ in Millions	3 Months Ended
	Nov. 30, 2024	Nov. 30, 2023
Derivative Financial Instrument Liabilities
Derivative warrant liabilities	$ 1.5
Gain loss on fair value	$ 0.8	$ 0.2

Earnings (loss) per share (Deta

Earnings (loss) per share (Details) - USD ($) $ in Thousands		3 Months Ended
		Nov. 30, 2024	Nov. 30, 2023
Notes and other explanatory information [abstract]
Net income (loss) attributable to shareholders		$ 981	$ (966)
Weighted average number of common shares for basic EPS	[1]	291,668,469	285,283,429
Effect of dilutive stock options, warrants, RSUs and share awards		1,826,542
Weighted average number of common shares for diluted EPS	[1]	293,495,011	285,283,429
[1]The weighted average number of common shares for basic and diluted EPS include 11.0 million gross number of vested, but unissued, common shares relating to common share awards.

Earnings (loss) per share (De_2

Earnings (loss) per share (Details Narrative) - shares shares in Millions	3 Months Ended
	Nov. 30, 2024	Nov. 30, 2023
Stock Options [Member]
IfrsStatementLineItems [Line Items]
Weighted average number of common shares	10.5	15.4
Warrants [member]
IfrsStatementLineItems [Line Items]
Weighted average number of common shares	36.2	39
Restricted Share Unit [Member]
IfrsStatementLineItems [Line Items]
Weighted average number of common shares	2.8	4.6

Share-based payments reserve (D

Share-based payments reserve (Details) - Canadian Dollars Denominated Stock Options [Member]	3 Months Ended
	Nov. 30, 2024 shares $ / shares
IfrsStatementLineItems [Line Items]
Number of shares outstanding, Beginning | shares	4,986,000
Weighted average exercise price, Beginning | $ / shares	$ 0.41
options exercised | shares	(562,000)	[1]
Weighted average exercise price, Option exercised | $ / shares	$ 0.42	[1]
Number of shares outstanding, Ending | shares	4,424,000
Weighted average exercise price, Ending | $ / shares	$ 0.41
[1]The weighted average share price at the time of the option exercise was C$0.53.

Share-based payments reserve _2

Share-based payments reserve (Details 1) - Stock Options [Member]	3 Months Ended
	Nov. 30, 2024 shares $ / shares
IfrsStatementLineItems [Line Items]
Exercise price | $ / shares	$ 0.41	[1]
Number of options outstanding	4,424,000
Number of options exercisable	4,424,000
Remaining contractual life	1 year 10 months 24 days	[1]
Range 1 [Member]
IfrsStatementLineItems [Line Items]
Exercise price | $ / shares	$ 0.40
Number of options outstanding	2,259,000
Number of options exercisable	2,259,000
Expiry date	Oct. 11, 2026
Remaining contractual life	1 year 10 months 24 days
Range 2 [Member]
IfrsStatementLineItems [Line Items]
Exercise price | $ / shares	$ 0.43
Number of options outstanding	2,065,000
Number of options exercisable	2,065,000
Expiry date	Sep. 29, 2026
Remaining contractual life	1 year 9 months 18 days
Range 3 [Member]
IfrsStatementLineItems [Line Items]
Exercise price | $ / shares	$ 0.35
Number of options outstanding	100,000
Number of options exercisable	100,000
Expiry date	Jan. 02, 2027
Remaining contractual life	2 years 1 month 6 days
[1]Total represents weighted average.

Share-based payments reserve _3

Share-based payments reserve (Details 2) - Stock Options 1 [Member]	Nov. 30, 2024 USD ($) $ / shares	Aug. 31, 2024 USD ($) $ / shares
IfrsStatementLineItems [Line Items]
Number of stock option | $	10,450,000	10,450,000
Weighted average exercise price per share | $ / shares	$ 0.49	$ 0.49

Share-based payments reserve _4

Share-based payments reserve (Details 3) - Stock Options 1 [Member]	3 Months Ended
	Nov. 30, 2024 $ / shares shares
IfrsStatementLineItems [Line Items]
Exercise price | $ / shares	$ 0.49	[1]
Number of options outstanding	10,450,000
Number of options exercisable	5,655,000
Remaining contractual life	3 years	[1]
Range 1 [Member]
IfrsStatementLineItems [Line Items]
Exercise price | $ / shares	$ 0.50
Number of options outstanding	7,375,000
Number of options exercisable	4,425,000
Expiry date	Aug. 17, 2027
Remaining contractual life	2 years 8 months 12 days
Range 2 [Member]
IfrsStatementLineItems [Line Items]
Exercise price | $ / shares	$ 0.45
Number of options outstanding	3,075,000
Number of options exercisable	1,230,000
Expiry date	Aug. 28, 2028
Remaining contractual life	3 years 8 months 12 days
[1]Total represents weighted average.

Share-based payments reserve _5

Share-based payments reserve (Details 4) - shares	Nov. 30, 2024	Aug. 31, 2024
Notes and other explanatory information [abstract]
Number of RSUs shares	1,498,385	1,498,385

Share-based payments reserve _6

Share-based payments reserve (Details Narrative) - USD ($) $ in Millions	3 Months Ended
	Nov. 30, 2024	Nov. 30, 2023	Aug. 31, 2024
IfrsStatementLineItems [Line Items]
Share based compensation expense	$ 0.2	$ 0.9
Stock Options [Member]
IfrsStatementLineItems [Line Items]
Share based compensation expense	0.1	0.2
Restricted Stock Unit [Member]
IfrsStatementLineItems [Line Items]
Share based compensation expense	$ 0.1	$ 0.5
Omnibus Equity Incentive Plan [Member]
IfrsStatementLineItems [Line Items]
Number of shares issued for options	6,942,109		5,997,632

Warrants reserve (Details)

Warrants reserve (Details) - $ / shares	3 Months Ended	12 Months Ended
	Nov. 30, 2024	Aug. 31, 2024
Warrants Reserve
Number of warrants outstanding, beginning balance	36,190,769
Weighted average exercise price per share, beginning balance	$ 0.62
Weighted average remaining contractual life (years)	1 year 8 months 12 days	1 year 10 months 24 days
Number of warrants outstanding, ending balance	36,190,769	36,190,769
Weighted average exercise price per share, ending balance	$ 0.62	$ 0.62

Warrants reserve (Details 1)

Warrants reserve (Details 1)	3 Months Ended
	Nov. 30, 2024 $ / shares shares
IfrsStatementLineItems [Line Items]
Number of warrants | shares	36,190,769
Warrants exercise price | $ / shares	$ 0.62	[1]
Private Placement Financing Warrants - February 11, 2021 [Member]
IfrsStatementLineItems [Line Items]
Number of warrants | shares	16,461,539
Warrants exercise price | $ / shares	$ 0.80
Warrants expiry date	February 11, 2026
Private Placement Financing Broker Warrants - February 11, 2021 [Member]
IfrsStatementLineItems [Line Items]
Number of warrants | shares	1,152,307
Warrants exercise price | $ / shares	$ 0.80
Warrants expiry date	February 11, 2026
Private Placement Financing Warrants – January 26, 2022 [Member]
IfrsStatementLineItems [Line Items]
Number of warrants | shares	17,948,718
Warrants exercise price | $ / shares	$ 0.44
Warrants expiry date	January 26, 2027
Private Placement Financing Placement Agent Warrants – January 26, 2022 [Member]
IfrsStatementLineItems [Line Items]
Number of warrants | shares	628,205
Warrants exercise price | $ / shares	$ 0.44
Warrants expiry date	January 26, 2027
[1]Total represents weighted average.

Non-controlling interest (Detai

Non-controlling interest (Details) - USD ($) $ in Thousands	3 Months Ended
	Nov. 30, 2024	Nov. 30, 2023	Aug. 31, 2024
IfrsStatementLineItems [Line Items]
Revenue	$ 12,528	$ 9,404
Income tax expense	1,693	1,191
Comprehensive income for the period	2,137	(39)
Current assets	16,843		$ 17,784
Current liabilities	20,395		21,283
Cash provided by operating activities	2,381	5,139
Cash used in investing activities	(3,700)	(4,060)
Cash used in financing activities	(225)	(381)
Non-controlling interests [member] | Buckreef [Member]
IfrsStatementLineItems [Line Items]
Revenue	12,528	9,404
Depreciation	906	484
Accretion expense	188	140
Income tax expense	1,693	1,191
Comprehensive income for the period	2,568	2,061
Current assets	10,746		11,297
Non-current assets	83,681		78,952
Current liabilities	(17,057)		(16,973)
Non-current liabilities	(13,863)		(11,528)
Advances from parent, net	(29,371)		$ (30,210)
Cash provided by operating activities	3,572	6,110
Cash used in investing activities	(3,675)	(4,057)
Cash used in financing activities	$ (1,090)	$ (1,089)

Related party transactions (Det

Related party transactions (Details) - USD ($) $ in Thousands	3 Months Ended
	Nov. 30, 2024	Nov. 30, 2023
Related Party Transactions
Remuneration	$ 366	$ 436
Share-based compensation expense	93	693
Total directors and key management personnel	$ 459	$ 1,129

Related party transactions (D_2

Related party transactions (Details Narrative) - USD ($)	3 Months Ended
	Nov. 30, 2024	Nov. 30, 2023
IfrsStatementLineItems [Line Items]
Shares granted	$ 0	$ 200,000
Stock Options [Member]
IfrsStatementLineItems [Line Items]
Compensation expense	100,000	200,000
RSUs [Member]
IfrsStatementLineItems [Line Items]
Compensation expense	$ 0	$ 300,000

General and administrative ex_3

General and administrative expenses (Details) - USD ($) $ in Thousands	3 Months Ended
	Nov. 30, 2024	Nov. 30, 2023
Notes and other explanatory information [abstract]
Directors’ fees (Note 16)	$ 64	$ 60
Insurance	61	85
Office and general	60	67
Shareholder information	151	158
Professional fees	169	189
Salaries and benefits (Note 16)	477	558
Consulting	215	177
Share-based compensation expense (Notes 13 and 16)	156	810
Travel and accommodation	52	78
Depreciation	15	13
Other	5	16
Total general and administrative expenses	$ 1,425	$ 2,211

Financial instruments (Details)

Financial instruments (Details) - USD ($) $ in Thousands	Nov. 30, 2024	Aug. 31, 2024
Measured at amortized cost
Amounts receivable	$ 2,307	$ 1,958
Measured at fair value through profit or loss
Cash	6,787	8,331
Measured at amortized cost
Amounts payables and accrued liabilities	15,876	15,545
Measured at fair value through profit or loss
Derivative financial instrument liabilities	$ 1,454	$ 2,273

Segmented Information (Details)

Segmented Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Nov. 30, 2024	Nov. 30, 2023
IfrsStatementLineItems [Line Items]
Total revenue	$ 12,528	$ 9,404
Tanzania [Member]
IfrsStatementLineItems [Line Items]
Total revenue	$ 12,528	$ 9,404

Segmented information (Details

Segmented information (Details 1) - USD ($) $ in Thousands	Nov. 30, 2024	Aug. 31, 2024
IfrsStatementLineItems [Line Items]
Total non-current assets	$ 85,789	$ 81,076
Canada [Member]
IfrsStatementLineItems [Line Items]
Total non-current assets	30	36
Tanzania [Member]
IfrsStatementLineItems [Line Items]
Total non-current assets	$ 85,759	$ 81,040

Segmented information (Detail_2

Segmented information (Details Narrative) - USD ($) $ in Millions	3 Months Ended
	Nov. 30, 2024	Nov. 30, 2023
Segmented Information
Revenue percentage	93%	90%
Revenue from customer	$ 11.6	$ 8.5

Non-cash items (Details)

Non-cash items (Details) - USD ($) $ in Thousands	3 Months Ended
	Nov. 30, 2024	Nov. 30, 2023
Non-cash Items
Depreciation	$ 921	$ 497
Change in fair value of derivative financial instruments (Note 11)	819	199
Share-based compensation expense (Note 13)	189	875
Accretion of provision for reclamation	36	27
Deferred income tax expense (Note 8)	1,291	899
Accretion of lease liabilities (Note 10)	70	1
Deferred revenue (Note 9)	(415)	578
Accretion of deferred revenue (Note 9)	84	112
Foreign exchange losses	190	165
Total non-cash items	$ 1,547	$ 2,955

Non-cash items (Details Narrati

Non-cash items (Details Narrative) - USD ($) $ in Millions	3 Months Ended
	Nov. 30, 2024	Nov. 30, 2023
Mineral Property Plant And Equipment [Member]
IfrsStatementLineItems [Line Items]
Amounts payable and accrued liabilities	$ 0.1	$ 0.6